logo

For the Inventor, By the Inventor

Evanston, IL, United States of America

Aptinyx Inc.


USPTO Granted Patents = 28



Trademarks = 1

Forward Citations = 364

Loading Chart...
Loading Chart...

2 inventors (with patents filed for the assignee):

goldMedal M Amin Khan (28 out of 46 patents)

silverMedal John Adams Lowe, Iii (13 out of 83 patents)

bronzeMedal John A Iii Lowe (0 patent)

4.  Amin M Khan (0 patent)

5.  John A Iii Lowe (0 patent)


28 patents:

1. 11578072 - Spiro-lactam NMDA receptor modulators and uses thereof (2023-02-14),
2. 11530223 - Spiro-lactam NMDA receptor modulators and uses thereof (2022-12-20),
3. 11512051 - Spiro-lactam NMDA receptor modulators and uses thereof (2022-11-29),
4. 11427585 - Spiro-lactam NMDA modulators and methods of using same (2022-08-30),
5. 11376250 - Spiro-lactam NMDA receptor modulators and uses thereof (2022-07-05),
6. 11370790 - Spiro-lactam NMDA modulators and methods of using same (2022-06-28),
7. 11299495 - Spiro-lactam NMDA receptor modulators and uses thereof (2022-04-12),
8. 11077094 - Spiro-lactam NMDA receptor modulators and uses thereof (2021-08-03),
9. 11028095 - Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof (2021-06-08),
10. 10961189 - Spiro-lactam NMDA receptor modulators and uses thereof (2021-03-30),
11. 10918637 - Spiro-lactam NMDA receptor modulators and uses thereof (2021-02-16),
12. 10441572 - Spiro-lactam NMDA receptor modulators and uses thereof (2019-10-15),
13. 10441571 - Spiro-lactam NMDA receptor modulators and uses thereof (2019-10-15),
14. 10316041 - Spiro-lactam NMDA receptor modulators and uses thereof (2019-06-11),
15. 10273239 - Spiro-lactam NMDA receptor modulators and uses thereof (2019-04-30),
Aptinyx Inc. is a biopharmaceutical company dedicated to the discovery and development of innovative therapies for challenging neurologic disorders. They aim to transform the lives of patients suffering from conditions such as post-traumatic stress disorder (PTSD), Parkinson's disease, and traumatic brain injury (TBI). By leveraging their deep expertise in the field of NMDA receptor modulation, Aptinyx is advancing a robust pipeline of candidates that have the potential to address unmet medical needs and provide improved outcomes for patients.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

...
28 Patents

#9 in Evanston, IL

#621 in Illinois

#11,595 in US

#22,553 in the World

...
Evanston, IL, United States of America

Aptinyx Inc.

Forward Citations = 364

2 inventors:

goldMedal M Amin Khan (28 out of 46 patents)

silverMedal John Adams Lowe, Iii (13 out of 83 patents)

bronzeMedal John A Iii Lowe (0 patent)

4.  Amin M Khan (0 patent)

5.  John A Iii Lowe (0 patent)

Please report any incorrect information to support@idiyas.com
Loading…